Invention Grant
US08722041B2 Anti-human equilibrative nucleoside transporter 1 (hENT1) antibodies and methods of use thereof
有权
抗人平衡核苷转运蛋白1（hENT1）抗体及其使用方法
- Patent Title: Anti-human equilibrative nucleoside transporter 1 (hENT1) antibodies and methods of use thereof
- Patent Title (中): 抗人平衡核苷转运蛋白1（hENT1）抗体及其使用方法
-
Application No.: US13161941Application Date: 2011-06-16
-
Publication No.: US08722041B2Publication Date: 2014-05-13
- Inventor: Marit L. Sandvold , Finn Myhren , Carol E. Cass , James D. Young
- Applicant: Marit L. Sandvold , Finn Myhren , Carol E. Cass , James D. Young
- Applicant Address: CA Edmonton
- Assignee: Governors of the University of Alberta
- Current Assignee: Governors of the University of Alberta
- Current Assignee Address: CA Edmonton
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/47 ; C07K16/28
Abstract:
This invention provides monoclonal antibodies that recognize hENT1. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and/or prophylactic in disorders associated with aberrant hENT1 expression and/or activity.
Public/Granted literature
- US20120009197A1 Anti-Human Equilibrative Nucleoside Transporter 1 (hENT1) Antibodies and Methods of Use Thereof Public/Granted day:2012-01-12
Information query
IPC分类:
